Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well fenretinide works in treating patients with
biochemically (rising PSA level) recurrent hormone-naïve (no previous hormone therapy)
prostate cancer. Drugs used in chemotherapy, such as fenretinide, work in different ways to
stop tumor cells from dividing so they stop growing or die